Stock Scorecard
Stock Summary for Dr. Reddy`s Laboratories Ltd (RDY) - $14.51 as of 3/10/2026 8:26:41 PM EST
Total Score
18 out of 30
Safety Score
48 out of 100
Currently on the following lists
None
Tim's Recommendation
Possible Buy
Growth List Algorithm Criteria for RDY
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for RDY
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for RDY
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for RDY
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for RDY (48 out of 100)
| Stock Price Rating (Max of 10) | 5 |
| Historical Stock Price Rating (Max of 10) | 5 |
| Stock Price Trend (Max of 10) | 9 |
| Book Value (Max of 10) | 3 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 3 |
| Analyst Strong Buy Ratings (Max of 5) | 0 |
| Dividend Yield Percentage (Max of 10) | 1 |
| Operating Margin (Max of 10) | 4 |
| Trading Volume (Max of 10) | 10 |
| Price to Earnings (Max of 10) | 8 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for RDY
Financial Details for RDY
Company Overview |
|
|---|---|
| Ticker | RDY |
| Company Name | Dr. Reddy`s Laboratories Ltd |
| Country | USA |
| Description | Dr. Reddy's Laboratories Limited is a globally integrated pharmaceutical company. The company is headquartered in Hyderabad, India. |
| Sector Name | HEALTHCARE |
| Industry Name | DRUG MANUFACTURERS - SPECIALTY & GENERIC |
| Most Recent Quarter | 12/31/2025 |
| Next Earnings Date | 5/8/2026 |
Stock Price History |
|
| Last Day Price | 14.51 |
| Price 4 Years Ago | 10.08 |
| Last Day Price Updated | 3/10/2026 8:26:41 PM EST |
| Last Day Volume | 2,015,699 |
| Average Daily Volume | 1,949,954 |
| 52-Week High | 16.07 |
| 52-Week Low | 12.18 |
| Last Price to 52 Week Low | 19.13% |
Valuation Measures |
|
| Trailing PE | 19.45 |
| Industry PE | 30.87 |
| Sector PE | 76.91 |
| 5-Year Average PE | 1.97 |
| Free Cash Flow Ratio | 0.65 |
| Industry Free Cash Flow Ratio | 12.44 |
| Sector Free Cash Flow Ratio | 22.97 |
| Current Ratio Most Recent Quarter | 1.88 |
| Total Cash Per Share | 22.41 |
| Book Value Per Share Most Recent Quarter | 4.86 |
| Price to Book Ratio | 2.97 |
| Industry Price to Book Ratio | 13.59 |
| Sector Price to Book Ratio | 21.80 |
| Price to Sales Ratio Twelve Trailing Months | 0.03 |
| Industry Price to Sales Ratio Twelve Trailing Months | 2.71 |
| Sector Price to Sales Ratio Twelve Trailing Months | 4.55 |
| Analyst Buy Ratings | 2 |
| Analyst Strong Buy Ratings | 0 |
Share Statistics |
|
| Total Shares Outstanding | 832,581,000 |
| Market Capitalization | 12,080,750,310 |
| Institutional Ownership | 13.44% |
Dividends |
|
| Ex-Dividend Date | 7/25/2025 |
| Previous Dividend Amount | 0.0952 |
| Current Dividend Amount | 0.0915 |
| Total Years Dividend Increasing | 0 |
| Trailing Annual Dividend Rate | 0.09 |
| Trailing Annual Dividend Yield | 0.64% |
| Forward Annual Dividend Rate | 0.09 |
| Forward Annual Dividend Yield | 0.64% |
| 5-Year Dividend Payments Count | 4 |
| 3-Year Average Dividend Yield | 0.66% |
| 5-Year Average Dividend Yield | 0.63% |
| 1-Year Dividend Growth Rate Percentage | -3.93% |
| 3-Year Dividend Growth Rate Percentage | -3.15% |
| 5-Year Dividend Growth Rate Percentage | 8.23% |
| All-Time Dividend Growth Rate Percentage | 10.38% |
| Dividend Payout Ratio | 12.36% |
Income Statement |
|
| Quarterly Earnings Growth YOY | -14.30% |
| Annual Earnings Growth | 1.54% |
| Reported EPS 12 Trailing Months | 0.74 |
| Reported EPS Past Year | 17.38 |
| Reported EPS Prior Year | 135.34 |
| Net Income Twelve Trailing Months | 56,586,000,000 |
| Net Income Past Year | 56,544,000,000 |
| Net Income Prior Year | 55,684,000,000 |
| Quarterly Revenue Growth YOY | 4.40% |
| 5-Year Revenue Growth | 13.27% |
| Operating Margin Twelve Trailing Months | 16.40% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 18,657,000,000 |
| Total Cash Past Year | 14,654,000,000 |
| Total Cash Prior Year | 7,107,000,000 |
| Net Cash Position Most Recent Quarter | 18,657,000,000 |
| Net Cash Position Past Year | 10,854,000,000 |
| Long Term Debt Past Year | 3,800,000,000 |
| Long Term Debt Prior Year | 3,800,000,000 |
| Total Debt Most Recent Quarter | 0 |
| Equity to Debt Ratio Past Year | 0.99 |
| Equity to Debt Ratio Most Recent Quarter | 1.00 |
| Total Stockholder Equity Past Year | 333,388,000,000 |
| Total Stockholder Equity Prior Year | 280,550,000,000 |
| Total Stockholder Equity Most Recent Quarter | 372,366,000,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 24,258,000,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 29.14 |
| Free Cash Flow Past Year | 12,030,000,000 |
| Free Cash Flow Prior Year | 17,998,000,000 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.00 |
| MACD Signal | 0.00 |
| 20-Day Bollinger Lower Band | 0.00 |
| 20-Day Bollinger Middle Band | 0.00 |
| 20-Day Bollinger Upper Band | 0.00 |
| Beta | 0.31 |
| RSI | 0.00 |
| 50-Day SMA | 0.00 |
| 150-Day SMA | 0.00 |
| 200-Day SMA | 0.00 |
System |
|
| Modified | 3/10/2026 6:49:38 AM EST |